"Off-the-Shelf" Combination CAdVEC and CAR-NK Cell Immunotherapy for Pancreatic Ductal Adenocarcinoma

被引:0
|
作者
Biegert, Greyson W. [1 ]
Shaw, Amanda Roswell [1 ]
Porter, Caroline E. [1 ]
Morita, Daisuke [2 ]
Suzuki, Masataka [1 ]
机构
[1] Baylor Coll Med, Houston, TX USA
[2] Shinshu Univ, Matsumoto, Nagano, Japan
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
327
引用
收藏
页码:176 / 177
页数:2
相关论文
共 50 条
  • [21] Leukoreduction filter derived NK cells offer a promising source for off the shelf CAR NK cell immunotherapy
    Ali Moazzeni
    Maryam Kheirandish
    Gholamreza Khamisipour
    Fatemeh Rahbarizadeh
    Ali Akbar Pourfathollah
    Scientific Reports, 15 (1)
  • [22] A novel CAR-NK cell therapy to target lung adenocarcinoma cells
    Zolov, Sergey
    Chuikov, Sergei
    Katkam, Shiva Krishna
    Shield, Delaney
    Keshamouni, Venkateshwar G.
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Dual CAR-Engineered NK92 Cells: An Off-the-Shelf Cell Therapy for Cancer
    Zuccolotto, Gaia
    Penna, Alessandro
    Fracasso, Giulio
    Santa, Silvia Dalla
    Carpanese, Debora
    Montagner, Isabella Monia
    Rossi, Valentina
    Tosi, Anna
    Rosato, Antonio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S440 - S440
  • [24] Tumor-activated human NK cells - Potential for "off-the-shelf" immunotherapy
    Lowdell, M. W.
    North, J.
    Bakhsh, I.
    Marden, C.
    Anderson, R.
    Pittman, H.
    Mackinnon, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 14 - 14
  • [25] FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies
    Goodridge, Jode P.
    Mahmood, Sajid
    Zhu, Huang
    Gaidarova, Svetlana
    Blum, Robert
    Bjordahl, Ryan
    Cichocki, Frank
    Chu, Hui-yi
    Bonello, Greg
    Lee, Tom
    Groff, Brian
    Meza, Miguel
    Walcheck, Bruce
    Malmberg, Karl-Johan
    Miller, Jeffrey S.
    Kaufman, Dan S.
    Valamehr, Bahram
    BLOOD, 2019, 134
  • [26] Advances in Off-the-Shelf CAR T-Cell Therapy
    Benjamin, Reuben
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 155 - 157
  • [27] Optimal, Off-the-Shelf, CAR-iNKT Cell Platform-Based Immunotherapy for Multiple Myeloma
    Ponnusamy, Kanagaraju
    Randzavola, Lyra
    Ren, Hongwei
    Karaxhuku, Klesti
    Lye, Bryan
    Leonardos, Dimitrios
    Nadafi, Reza
    Sarkar, Irene
    Leontari, Ilia
    Sabrin, Farah
    Zaidi, Mehmood
    Bua, Marco
    Atta, Maria
    Katsarou, Alexia
    Roberts, Irene
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    BLOOD, 2023, 142
  • [28] T-Cell Engineering For "off-The-shelf" Adoptive Immunotherapy
    Poirot, Laurent
    Schiffer-Mannioui, Cecile
    Philip, Brian
    Derniame, Sophie
    Gouble, Agnes
    Chion-Sotinel, Isabelle
    Le Clerre, Diane
    Lemaire, Laetitia
    Grosse, Stephanie
    Cheung, Gordon
    Arnould, Sylvain
    Smith, Julianne
    Pule, Martin
    Scharenberg, Andrew
    BLOOD, 2013, 122 (21)
  • [29] Off-the-Shelf, Multiplexed-Engineered iPSC-Derived CD33 CAR-NK Cells for Treatment of Acute Myeloid Leukemia
    Wang, Yiyun
    Wang, Linqin
    Shao, Mi
    He, Xiangjun
    Yue, Yanan
    Zhou, Yixuan
    Yang, Luhan
    Huang, He
    Hu, Yongxian
    BLOOD, 2022, 140 : 12685 - 12685
  • [30] NKX019, AN OFF-THE-SHELF CD19 CAR-NK CELL, MEDIATES IMPROVED ANTI-TUMOR ACTIVITY AND PERSISTENCE IN COMBINATION WITH CD20-DIRECTED THERAPEUTIC MABS
    Tohme, Mira
    Davis, Tina
    Zhang, Max
    Lemar, Hadia
    Duong, Bao
    Tan, Joanne
    Trager, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A940 - A940